SIBN

SI-BONE, Inc.

$25.10

-1.95%
SectorHealthcareIndustryMedical DevicesCountryUnited States

SI-BONE, Inc., a medical device company, develops procedural solutions for compromised bone, grounded in expertise in biomechanical design and anatomy-specific applications in the United States and internationally. It offers a series of patented titanium implants and the instruments used to implant them, as well as implantable bone products.

Source: Yahoo Finance
AI summary

Price & performance

1M+38.0%
3M+35.3%
YTD+26.1%
1Y+62.5%
52-week range—
Beta0.95
Full chart and returns against a benchmark

Q-Score

64/ 100

Quality against peers; 50 is the peer median.

Growth67
Risk67
Performance57
Valuation52
Profitability62
Leverage56
Sentiment51
Every score and metric

News sentiment

Open News

Latest results · FY 2025

Revenue$200.9M+20.2%
Net income-$18.9M
Net margin-9.4%+9.1 pts
Historical fundamentals

Revenue exposure

5%of revenue from outside the US
United States95%
Non-US5%
Regions, segments, customers and suppliers

Valuation

SIBNIndustryP/E—29.61P/S5.133.49EV/EBITDA—18.38P/B6.133.39PEG——
Dividend yield0.00%
Every valuation metric

Earnings

Nov 2next report
EPS estimate$-0.13
Beats (last 4 quarters)—
Average surprise—
EPS revisions (30d)—
Every quarter against its estimate